article thumbnail

Roche licenses Sangamo’s technology for another shot at Alzheimer’s drugs

Bio Pharma Dive

Through a new deal, Roche has exclusive rights to Sangamo molecules designed to repress the gene that makes “tau,” a protein many scientists view as a main driver of Alzheimer’s.

Licensing 330
article thumbnail

Shakeup with Optum’s health data licensing sparks an outcry among scientists

STAT News

A move by Optum to change longstanding practices for licensing data to academic institutions has sparked an outcry among researchers, who argue the move will make accessing data so costly and difficult that universities will scale back their research programs.

Licensing 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gene editing biotechs face new uncertainty after CRISPR patent ruling

Bio Pharma Dive

A federal patent board ruled Broad Institute scientists were first to a key gene editing advance, weakening the patent position of Intellia and CRISPR Therapeutics, which hold licenses through the University of California.

article thumbnail

Clinical Scientist Jobs: The Steps to Succeed in This Role

XTalks

If you enjoy working with biological samples and are enthusiastic about healthcare, a career as a clinical scientist might be just right for you. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform. Who is a Clinical Scientist? What is it Like to Work as a Clinical Scientist?

Scientist 105
article thumbnail

Field Application Scientist Jobs: Everything You Need to Know

XTalks

A field application scientist is a valuable member of any life science company due to their direct interaction with customers. Field application scientists help laboratory groups successfully install and apply the newest scientific supplies, equipment, instruments and software. Field Scientist Job Description.

article thumbnail

Hong Kong pulls visa for ‘CRISPR babies’ scientist He Jiankui

STAT News

BEIJING — Hong Kong on Tuesday revoked a visa it granted to a Chinese scientist who set off an ethical debate five years ago with claims that he made the world’s first genetically edited babies, pulling it hours after he announced his research plans in the financial hub. Read the rest…

article thumbnail

Gilead wins patent battle with US government over HIV PrEP drugs

Pharmaceutical Technology

According to the US government, Gilead had repeatedly refused to license patents related to PrEP research undertaken by the Department of Health and Human Services’ (HHS) Centers for Disease Control and Prevention (CDC). This research dates to the mid-2000s when CDC scientists developed the PrEP regimen, argued the government.

Drugs 264